Omeros (OMER) Revenue (2010 - 2026)
Omeros recorded quarterly Revenue of $9.9 million in Q1 2026, down 67.03% quarter-over-quarter from $30.0 million in Q3 2021.
Omeros' Revenue history runs 13 years deep, the most recent figure standing at $9.9 million for Q1 2026.
- In Q1 2026, Revenue changed N/A year-over-year to $9.9 million; the TTM figure through Mar 2026 stood at $68.7 million (down 13.98% YoY), while the FY2020 annual figure was $73.8 million, down 33.98% from the prior year.
- Revenue came in at $9.9 million for Q1 2026 at Omeros, down from $30.0 million in the prior quarter.
- In the past five years, Revenue ranged from a high of $9.9 million in Q1 2026 to a low of $9.9 million in Q1 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 306.30 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 2.99 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 3.61 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1.17 Bn |
| 10 | Omeros | 772.03 Mn | 636.71 Mn | 9.31 Mn | 9.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.89 Mn |
| Sep 30, 2021 | 30.00 Mn |
| Jun 30, 2021 | 28.82 Mn |
| Mar 31, 2021 | 21.06 Mn |
| Dec 31, 2020 | 10.63 Mn |
| Sep 30, 2020 | 26.11 Mn |
| Jun 30, 2020 | 13.53 Mn |
| Mar 31, 2020 | 23.54 Mn |
| Dec 31, 2019 | 33.42 Mn |
| Sep 30, 2019 | 29.86 Mn |
| Jun 30, 2019 | 26.75 Mn |
| Mar 31, 2019 | 21.78 Mn |
| Dec 31, 2018 | 22.02 Mn |
| Sep 30, 2018 | 4.61 Mn |
| Jun 30, 2018 | 1.66 Mn |
| Mar 31, 2018 | 1.59 Mn |
| Dec 31, 2017 | 13.76 Mn |
| Sep 30, 2017 | 21.66 Mn |
| Jun 30, 2017 | 17.15 Mn |
| Mar 31, 2017 | 12.26 Mn |
| Dec 31, 2016 | 12.91 Mn |
| Sep 30, 2016 | 11.29 Mn |
| Jun 30, 2016 | 10.00 Mn |
| Mar 31, 2016 | 7.42 Mn |
| Dec 31, 2015 | 6.68 Mn |
| Sep 30, 2015 | 3.26 Mn |
| Jun 30, 2015 | 3.19 Mn |
| Mar 31, 2015 | 388,000.00 |
| Dec 31, 2014 | 180,000.00 |
| Sep 30, 2014 | 214,000.00 |
| Jun 30, 2014 | 45,000.00 |
| Mar 31, 2014 | 100,000.00 |
| Dec 31, 2013 | 169,000.00 |
| Sep 30, 2013 | 196,000.00 |
| Jun 30, 2013 | 140,000.00 |
| Mar 31, 2013 | 1.10 Mn |
| Dec 31, 2012 | 1.58 Mn |
| Sep 30, 2012 | 1.42 Mn |
| Jun 30, 2012 | 1.53 Mn |
| Mar 31, 2012 | 1.50 Mn |
| Dec 31, 2011 | 1.14 Mn |
| Sep 30, 2011 | 987,000.00 |
| Jun 30, 2011 | 1.16 Mn |
| Mar 31, 2011 | 1.24 Mn |
| Dec 31, 2010 | 976,000.00 |
| Sep 30, 2010 | 254,000.00 |
| Jun 30, 2010 | 497,000.00 |